Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 6 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Mgi Tech Co. Ltd. has 10 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 10 distinct examiners and 8 distinct art units, indicating full examiner dispersion alongside some art-unit overlap.
GOCO, JOHN PATRICK is the busiest examiner, with 1 pending matter. Counsel should maintain matter-level tracking across the examiner group while looking for recurring issues within shared art-unit settings.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (25%) |
| §112 only | 1 (12%) |
| Multi-statute (no §101) | 5 (62%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOCO, JOHN PATRICK | 1 | 50.0% | +75.0% |
| LAFAVE, ELIZABETH ROSE | 1 | 64.4% | +43.2% |
| POHNERT, STEVEN C | 1 | 12.5% | +18.2% |
| KAUP, SAHANA S | 1 | 44.5% | +29.7% |
| SHI, TINGCHEN | 1 | 69.4% | +22.7% |
| BROWN, MINDY G | 1 | 57.8% | +40.5% |
| SCHLOOP, ALLISON ELIZABETH | 1 | 63.3% | +47.6% |
| BAILEY, STEVEN WILLIAM | 1 | 31.6% | +15.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17919341 | FLUID LAYING DEVICE, FLUID LAYING METHOD, FLUID LAYING SYSTEM, COMPOSITE DEVICE, AND FLUID PASSAGE DEVICE | SHI, TINGCHEN | 8d overdue |
| 18983916 | SYNTHETIC IMAGE GENERATION AND MACHINE LEARNING ANALYSIS FOR BIOLOGICAL SUBSTANCES | GOCO, JOHN PATRICK | — |
| 18689293 | METHOD FOR ANALYZING SEQUENCE OF TARGET POLYNUCLEOTIDE | LAFAVE, ELIZABETH ROSE | — |
| 18689062 | METHOD FOR ANALYZING SEQUENCE OF TARGET POLYNUCLEOTIDE | POHNERT, STEVEN C | — |
| 18582080 | TEMPLATE MUTAGENESIS FOR IMPROVED ASSEMBLY OF SEQUENCE READS | KAUP, SAHANA S | — |
| 17912008 | RESTORING PHASE IN MASSIVELY PARALLEL SEQUENCING | BROWN, MINDY G | — |
| 17756625 | RANDOM EMULSIFICATION DIGITAL ABSOLUTE QUANTITATIVE ANALYSIS METHOD AND DEVICE | BAILEY, STEVEN WILLIAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17919341 | FLUID LAYING DEVICE, FLUID LAYING METHOD, FLUID LAYING SYSTEM, COMPOSITE DEVICE, AND FLUID PASSAGE DEVICE | SHI, TINGCHEN | 8d overdue |
| 18983916 | SYNTHETIC IMAGE GENERATION AND MACHINE LEARNING ANALYSIS FOR BIOLOGICAL SUBSTANCES | GOCO, JOHN PATRICK | — |
| 18689293 | METHOD FOR ANALYZING SEQUENCE OF TARGET POLYNUCLEOTIDE | LAFAVE, ELIZABETH ROSE | — |
| 18689062 | METHOD FOR ANALYZING SEQUENCE OF TARGET POLYNUCLEOTIDE | POHNERT, STEVEN C | — |
| 18582080 | TEMPLATE MUTAGENESIS FOR IMPROVED ASSEMBLY OF SEQUENCE READS | KAUP, SAHANA S | — |
| 17912008 | RESTORING PHASE IN MASSIVELY PARALLEL SEQUENCING | BROWN, MINDY G | — |
| 17863808 | METHOD FOR SYNCHRONOUSLY SEQUENCING SENSE STRAND AND ANTISENSE STRAND OF DNA | SCHLOOP, ALLISON ELIZABETH | — |
| 17756625 | RANDOM EMULSIFICATION DIGITAL ABSOLUTE QUANTITATIVE ANALYSIS METHOD AND DEVICE | BAILEY, STEVEN WILLIAM | — |
| Art Unit | Apps |
|---|---|
| 1683 | 3 |
| 2611 | 1 |
| 1684 | 1 |
| 1612 | 1 |
| 1796 | 1 |
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18983916 | SYNTHETIC IMAGE GENERATION AND MACHINE LEARNING ANALYSIS FOR BIOLOGICAL SUBSTANCES | GOCO, JOHN PATRICK | 2611 | §101§103 | Non-Final OA | — | Pending | Dec 17, 2024 |
| 18689293 | METHOD FOR ANALYZING SEQUENCE OF TARGET POLYNUCLEOTIDE | LAFAVE, ELIZABETH ROSE | 1684 | §103§112 | Non-Final OA | — | Pending | Mar 05, 2024 |
| 18689062 | METHOD FOR ANALYZING SEQUENCE OF TARGET POLYNUCLEOTIDE | POHNERT, STEVEN C | 1683 | §103§112 | Non-Final OA | — | Pending | Mar 04, 2024 |
| 18582080 | TEMPLATE MUTAGENESIS FOR IMPROVED ASSEMBLY OF SEQUENCE READS | KAUP, SAHANA S | 1612 | §103§112 | Non-Final OA | — | Pending | Feb 20, 2024 |
| 17919341 | FLUID LAYING DEVICE, FLUID LAYING METHOD, FLUID LAYING SYSTEM, COMPOSITE DEVICE, AND FLUID PASSAGE DEVICE | SHI, TINGCHEN | 1796 | §102§103§112 | Final Rejection | 8d overdue | Pending | Oct 17, 2022 |
| 17912008 | RESTORING PHASE IN MASSIVELY PARALLEL SEQUENCING | BROWN, MINDY G | 1683 | §102§103§112 | Non-Final OA | — | Pending | Sep 15, 2022 |
| 17863808 | METHOD FOR SYNCHRONOUSLY SEQUENCING SENSE STRAND AND ANTISENSE STRAND OF DNA | SCHLOOP, ALLISON ELIZABETH | 1683 | §112 | Final Rejection | — | Pending | Jul 13, 2022 |
| 17756625 | RANDOM EMULSIFICATION DIGITAL ABSOLUTE QUANTITATIVE ANALYSIS METHOD AND DEVICE | BAILEY, STEVEN WILLIAM | 1687 | §101§103§112DP | Non-Final OA | — | Pending | May 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMgi Tech Co. Ltd. has 8 pending office actions as of October 2026, spread across 6 art units and 8 examiners.
John Patrick Goco has the most, with 1 of Mgi Tech Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
